AstraZeneca Asks Fed. Circ. To Reopen Nexium Patent Suit
AstraZeneca AB on Tuesday asked the Federal Circuit to revive its suit against Hanmi Pharmaceutical Co. Ltd., arguing a lower court had wrongly found that the South Korean drugmaker's copycat version...To view the full article, register now.
Already a subscriber? Click here to view full article